Skip to main content
. Author manuscript; available in PMC: 2015 Apr 11.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):174–184. doi: 10.1097/QAI.0b013e31815b0792

Figure 3.

Figure 3

Figure 3A. VAT Based on BMI Class Among HIV-Infected and Control Males

Results are expressed as mean±standard deviation.

The white bar denotes HIV-infected subjects while the black bar denotes non-HIV-infected controls.

BMI categories defined using WHO criteria17, as follows:
  • Normal Weight = BMI 18.5 – 24.9
  • Overweight = BMI 25.0 – 29.9
  • Obese = BMI ≥ 30.0).

P values derived from ANOVA test to determine differences between HIV-infected and non-HIV-infected subjects

Abbreviations: VAT, Visceral Adipose Tissue; BMI, Body Mass Index

Figure 3B. SAT Based on BMI Class Among HIV-Infected and Control Males

Results are expressed as mean±standard deviation.

The white bar denotes HIV-infected subjects while the black bar denotes non-HIV-infected controls.

BMI categories defined using WHO criteria 17, as follows:
  • Normal Weight = BMI 18.5 – 24.9
  • Overweight = BMI 25.0 – 29.9
  • Obese = BMI ≥ 30.0).

P values derived from ANOVA test to determine differences between HIV-infected and non-HIV-infected subjects

Abbreviations: SAT, Subcutaneous Adipose Tissue; BMI, Body Mass Index